Advanced Filters
Loading...
Found 7 Lung trials
Below is a list of actively recruiting clinical trials based on your search for "Lung"
Program with 2 clinical trials
These clinical studies are investigating the safety and efficacy of an investigational medication for patients with moderate to severe COPD and who are either current smokers or have a history of smoking.
Featured study
This study investigates the effects of an investigational medication on airway inflammation, resistance, and remodeling, including mucus plugging, in individuals with Chronic Obstructive Pulmonary Disease (COPD).The study evaluates how these factors relate to lung function, exacerbations, and quality of life.Who can participate: Participants aged 40 to 85 years with a …
This study investigates chronic lung allograft dysfunction. It focuses on evaluating the effectiveness and safety of an investigational medication.The study evaluates how the investigational medication works compared to a placebo. It looks at safety and effectiveness when used with standard treatments.Who can participate: Adults aged 18 and older who are …
This study investigates advanced solid tumors.The study evaluates the safety of an investigational medication in participants with solid tumors that are hard to treat or have spread throughout the body.Who can participate: Adults with metastatic or unresectable solid tumors that have relapsed or are refractory to treatment. Participants must have …
This study investigates the effectiveness of different investigational medications compared to a placebo in improving lung capacity in participants with Interstitial Lung Disease (ILD) secondary to Systemic Sclerosis (SSc). The purpose is to observe changes from the start to the end of the treatment period at Week 52.Participants in the …
This study investigates advanced pancreatic cancer, non-small cell lung cancer, and colorectal cancer with KRAS mutations. The purpose of this study is to explore how the investigational medication affects these conditions.The study evaluates the safety, tolerability, and other effects of the investigational medication. It looks at how the body processes …
This study investigates COPD exacerbation. It looks at how an AI-enabled clinical workflow tool can affect follow-up care and outcomes for patients after an acute exacerbation.The study evaluates the use of this tool to see if it improves respiratory specialist follow-up and clinical outcomes. It does not focus on how …
Please choose between Voice or SMS based delivery of verification code
or